Biswakanth Kar

2.0k citations
123 papers · 1.4k indexed · 1 hit paper · h-index 18

Biswakanth Kar

104 papers receiving 1.3k citations

Hit Papers

Current Treatment Strategies Against Multidrug-Resistant ...14820222026202320244080120

Peers

Biswakanth Kar
Comparison fields: 5 of 108
  • Pharmacology 215
  • Biochemistry 141
  • Molecular Medicine 92
  • Pharmaceutical Science 111
  • Toxicology 61
Replace Dorina Coricovac with:
Dorina Coricovac Romania
Marius Mioc Romania
Muhammad Asif Pakistan
Barkat Ali China
Shasank S. Swain India
Iulia Pînzaru Romania
Gamal A. Soliman Egypt
Teresinha Gonçalves da Silva Brazil
Shabana Bibi Pakistan
Ram Kumar Sahu India
Biswakanth Kar relative to Dorina Coricovac Romania Dorina Coricovac's profile →
Citations per field
00.5×1.5×1.9×
Dorina Coricovac · 1×
Citations per year

Countries citing papers authored by Biswakanth Kar

Since Specialization
Citations

This map shows the geographic impact of Biswakanth Kar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Biswakanth Kar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Biswakanth Kar more than expected).

Fields of papers citing papers by Biswakanth Kar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Biswakanth Kar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Biswakanth Kar. The network helps show where Biswakanth Kar may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Biswakanth Kar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Biswakanth Kar Line = papers co-authored together Biswakanth Kar links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20250
3 20240
4 20245
5 202412
6 20249
7 20244
8 20240
9 20243
10 20241
11 20230
12 202320
13 20235
14 20232
15
Current Treatment Strategies Against Multidrug-Resistant Bacteria: A Reviewbreakdown →
2022148
16 20211
17 20212
18
Hepatoprotective activity of Euphorbia neriifolia against paracetamol induced hepatotoxicity in rats
20153
19
ANTIHYPERGLYCEMIC EFFECT AND ANTIOXIDANT PROPERTY OF CITRUS MAXIMA LEAF IN STREPTOZOTOCIN- INDUCED DIABETIC RATS
201114
20
Acute and Sub-chronic Toxicity Study of Dregea volubilis Fruit in Mice
20108

About Biswakanth Kar

Biswakanth Kar is a scholar working on Drug Discovery, Pharmacology and Pharmaceutical Science, having authored 123 papers that have together received 1.4k indexed citations. Recurring topics across this work include Natural Antidiabetic Agents Studies (20 papers), Advanced Drug Delivery Systems (18 papers), Pharmacological Effects of Natural Compounds (15 papers), Natural product bioactivities and synthesis (12 papers), Essential Oils and Antimicrobial Activity (12 papers), Phytochemicals and Antioxidant Activities (11 papers), Drug-Induced Hepatotoxicity and Protection (10 papers) and Nanoparticle-Based Drug Delivery (8 papers). The work is most often cited by research in Pharmacology (215 citations), Biochemistry (141 citations) and Molecular Medicine (92 citations). Biswakanth Kar has collaborated with scholars based in India, Saudi Arabia and Australia. Frequent co-authors include Pallab Kanti Haldar, Asis Bala, Goutam Rath, Goutam Ghosh, Upal Kanti Mazumder, Deepak Pradhan, Jitu Halder, Sanjib Bhattacharya, Indrajit Karmakar and Narayan Dolai. Their work appears in journals such as AAPS PharmSciTech, Journal of Drug Delivery Science and Technology, Journal of Ethnopharmacology, Current Pharmaceutical Design and International Journal of Biological Macromolecules.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026